Commentary: A framework for assessment of adverse events in psychedelic research.
Journal of psychopharmacology (Oxford, England) May 1, 2025 Katherine Cheung, Rebecca Ehrenkranz, Jared T Hinkle et al. 1 citation
A commentary responds to a proposed framework for assessing adverse events in psychedelic-assisted therapies, which includes spiritual, existential, religious, and theological impacts. The authors argue that adverse event assessment in psychedelic clinical trials should match the rigor and standards of other research areas, and emphasize the need for transparency and accessibility in reporting. The commentary discusses the framework's feasibility and various assessment methods, focusing on ensuring systematic and unbiased evaluation of adverse events.